focus -WSS

focus

author：explore 2025-10-01 17:20:15 - browse：972

A glass office building of MassMutual with its sign on the top left — insurance coverage from STAT — Adobe

One of the country’s biggest life insurers is venturing into genetic testing, an area that’s historically been a minefield for that industry, in a purported effort to keep its members alive longer.

MassMutual announced Tuesday that it’s offering many of its 4.2 million policyholders free genetic risk assessments for eight common diseases, like heart disease, type 2 diabetes, and breast cancer. The Springfield, Mass.-based insurer hopes that when people learn they carry a genetic predisposition, they’ll take action to lower their risk through diet, exercise, and getting regular screenings.

Viewed one way, it’s a win-win: The longer its members live, the longer MassMutual can collect and invest their premiums without paying out.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Elizabeth Holmes banned from government health programs

WSS

Abridge raises $150m as clinical notes automation market heats up

Biotech venture capitalists face new demands from investors

Elizabeth Holmes banned from government health programs

A new drug could help frostbite victims avoid its ravages

Reporting on presidential health from Reagan to Trump and Biden

Ukraine seeks to reclaim its role as a hub for clinical trials

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

entertainment

Cancer drug shortages should be causing more outrage

The surgeon had a dilemma only a Nazi medical text could resolve

Jerome Adams on the need for new antivirals for Covid

WATCH: Why do our ears pop?

United colonoscopy coverage change 'may cost lives,' doctors say

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

In age of alternative facts, a scholarly course on calling out crap

Think you might have Covid

Medicare details structure of new drug price negotiation program

Secretariat’s lessons for human medicine

knowledge

Secretariat’s lessons for human medicine

New CMS data security rules will hurt Medicare, Medicaid research

Secretariat’s lessons for human medicine

A new drug could help frostbite victims avoid its ravages

Opioid cravings were reduced by anti

Congress may force more Covid

hotspot

hotspot

hotspot

knowledge